Announced

Completed

ArchiMed completed the acquisition of a majority stake in Namsa.

Synopsis

European healthcare investment firm ArchiMed completed the acquisition of a majority stake in Namsa, a medical device testing company. Financial terms were not disclosed. Namsa chose ArchiMed in part because of its knowledge of the European market, one of the areas where Namsa hopes to expand. The deal is expected to close in September.

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

All rights reserved. Copyright © 2025 Datasite

MergerLinks - ArchiMed completed the acquisition of a majority stake in Namsa.